Skip to main content

Table 1 the comparison of demographic characteristics of infants between the two groups

From: The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial

Variables

Surfactant group (n = 67)

Surfactant + budesonide group (n = 67)

Gestational age (week)

Mean (SD)

31 ± 2.96

31.66 ± 2.84

Birth weight (gr)

Mean (SD)

1465.45 ± 520.88

1584.55 ± 505.02

Maternal age (year)

Mean (SD)

29.97 ± 6.45

29.12 ± 4.86

Delivery mode

NVD (n %)

19(28.4%)

18(26.9%)

CS (n %)

48(71.6%)

49(73.1%)

Sex

Male (n %)

40(59.7%)

29(43.3%)

Female (n %)

27(40.3%)

38(56.7%)

Maternal medical problems

Yes

22(32.8%)

19(28.4%)

No

45(67.2%)

48(71.6%)

Antenatal drug

No

32(47.8%)

33(49.3%)

Betamethasone

11(16.4%)

17(25.4%)

Levothyroxine

3(4.5%)

5(7.5%)

Combination

21(31.3%)

12(17.9%)

Gestational age (week)

< 30

24(35.8%)

16(23.9%)

30–34

39(58.2%)

32(47.8%)

> 34

12(17.9%)

11(16.4%)

Birth weight (gr)

< 1500

30(44.8)

40(59.7)

1500–2000

22(32.8)

13(19.4)

> 2000

15(22.4)

14(20.9)